 | • レポートコード：QY2108PAL8817 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、143ページ • 納品方法：Eメール（納期：1日） • 産業分類：医薬品 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の当調査資料ではグローバルにおける好酸球性食道炎治療薬の市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、好酸球性食道炎治療薬の種類別市場規模（ブデソニド、フルチカゾン、その他）、用途別市場規模（病院、診療所、ドラッグストア）も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。 ・調査の概要 ・調査のサマリー ・世界の好酸球性食道炎治療薬市場動向 ・グローバル主要プレイヤーの競争状況・市場シェア ・世界における好酸球性食道炎治療薬の種類別市場規模（2016年-2027年）：ブデソニド、フルチカゾン、その他 ・世界における好酸球性食道炎治療薬の用途別市場規模（2016年-2027年）：病院、診療所、ドラッグストア ・好酸球性食道炎治療薬の中国市場分析 - 好酸球性食道炎治療薬の中国市場規模（2016年-2027年） - 中国における好酸球性食道炎治療薬の主要プレイヤー別市場シェア - 中国における好酸球性食道炎治療薬の種類別市場規模：ブデソニド、フルチカゾン、その他 - 中国における好酸球性食道炎治療薬の用途別市場規模：病院、診療所、ドラッグストア ・好酸球性食道炎治療薬の北米市場（2016年-2027年） ・好酸球性食道炎治療薬のヨーロッパ市場（2016年-2027年） ・好酸球性食道炎治療薬のアジア太平洋市場（2016年-2027年） ・好酸球性食道炎治療薬の中南米市場（2016年-2027年） ・好酸球性食道炎治療薬の中東・アフリカ市場（2016年-2027年） ・主要プレイヤーの情報：AstraZeneca、GSK、Bayer、Adare Pharmaceuticals、DBV Technologies、Dr. Falk Pharma、Quorum Innovations、Takeda、Calypso、Celgene、Regeneron ・市場機会・課題・リスク要因分析 ・バリューチェーン・販売チャネル分析 ・... |
Eosinophilic esophagitis (EoE, also spelled eosinophilic oesophagitis), also known as allergic oesophagitis, is an allergic inflammatory condition of the esophagus that involves eosinophils, a type of white blood cell. Symptoms are swallowing difficulty, food impaction, vomiting, and heartburn.
Eosinophilic esophagitis was first described in children but also occurs in adults. The condition is not well understood, but food allergy may play a significant role. The treatment may consist of removal of known or suspected triggers and medication to suppress the immune response.
This report studies the eosinophilic esophagitis drug market.
AstraZeneca, GSK and Bayer are the leading producers of eosinophilic esophagitis drug, which together account for about 80% of the market.
North America is the leading region, accounting for more than 30% of the market, followed by Europe at nearly 30%.
Market Analysis and Insights: Global and China Eosinophilic Esophagitis Drug Market
This report focuses on global and China Eosinophilic Esophagitis Drug market.
In 2020, the global Eosinophilic Esophagitis Drug market size was US$ 123 million and it is expected to reach US$ 178.9 million by the end of 2027, with a CAGR of 5.5% during 2021-2027. In China the Eosinophilic Esophagitis Drug market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.
Global Eosinophilic Esophagitis Drug Scope and Market Size
Eosinophilic Esophagitis Drug market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Eosinophilic Esophagitis Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Eosinophilic Esophagitis Drug market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.
Segment by Type
Budesonide
Fluticasone
Others
Segment by Application
Hospitals
Clinics
Drugstore
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
AstraZeneca
GSK
Bayer
Adare Pharmaceuticals
DBV Technologies
Dr. Falk Pharma
Quorum Innovations
Takeda
Calypso
Celgene
Regeneron
1 Study Coverage
1.1 Eosinophilic Esophagitis Drug Product Introduction
1.2 Market by Type
1.2.1 Global Eosinophilic Esophagitis Drug Market Size Growth Rate by Type
1.2.2 Budesonide
1.2.3 Fluticasone
1.2.4 Others
1.3 Market by Application
1.3.1 Global Eosinophilic Esophagitis Drug Market Size Growth Rate by Application
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Drugstore
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Eosinophilic Esophagitis Drug Market Size, Estimates and Forecasts
2.1.1 Global Eosinophilic Esophagitis Drug Revenue 2016-2027
2.1.2 Global Eosinophilic Esophagitis Drug Sales 2016-2027
2.2 Global Eosinophilic Esophagitis Drug, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Eosinophilic Esophagitis Drug Historical Market Size by Region (2016-2021)
2.3.1 Global Eosinophilic Esophagitis Drug Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Eosinophilic Esophagitis Drug Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Eosinophilic Esophagitis Drug Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Eosinophilic Esophagitis Drug Sales Forecast by Region (2022-2027)
2.4.2 Global Eosinophilic Esophagitis Drug Revenue Forecast by Region (2022-2027)
3 Global Eosinophilic Esophagitis Drug Competitor Landscape by Players
3.1 Global Top Eosinophilic Esophagitis Drug Manufacturers by Sales
3.1.1 Global Eosinophilic Esophagitis Drug Sales by Manufacturer (2016-2021)
3.1.2 Global Eosinophilic Esophagitis Drug Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Eosinophilic Esophagitis Drug Manufacturers by Revenue
3.2.1 Key Eosinophilic Esophagitis Drug Manufacturers Covered: Ranking by Revenue
3.2.2 Global Eosinophilic Esophagitis Drug Revenue by Manufacturers (2016-2021)
3.2.3 Global Eosinophilic Esophagitis Drug Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Eosinophilic Esophagitis Drug Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Eosinophilic Esophagitis Drug Revenue in 2020
3.2.6 Global Eosinophilic Esophagitis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Eosinophilic Esophagitis Drug Price by Manufacturers
3.4 Global Eosinophilic Esophagitis Drug Manufacturing Base Distribution, Product Types
3.4.1 Eosinophilic Esophagitis Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Eosinophilic Esophagitis Drug Product Type
3.4.3 Date of International Manufacturers Enter into Eosinophilic Esophagitis Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Eosinophilic Esophagitis Drug Market Size by Type (2016-2021)
4.1.1 Global Eosinophilic Esophagitis Drug Sales by Type (2016-2021)
4.1.2 Global Eosinophilic Esophagitis Drug Revenue by Type (2016-2021)
4.1.3 Eosinophilic Esophagitis Drug Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Eosinophilic Esophagitis Drug Market Size Forecast by Type (2022-2027)
4.2.1 Global Eosinophilic Esophagitis Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Eosinophilic Esophagitis Drug Revenue Forecast by Type (2022-2027)
4.2.3 Eosinophilic Esophagitis Drug Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Eosinophilic Esophagitis Drug Market Size by Application (2016-2021)
5.1.1 Global Eosinophilic Esophagitis Drug Sales by Application (2016-2021)
5.1.2 Global Eosinophilic Esophagitis Drug Revenue by Application (2016-2021)
5.1.3 Eosinophilic Esophagitis Drug Price by Application (2016-2021)
5.2 Eosinophilic Esophagitis Drug Market Size Forecast by Application (2022-2027)
5.2.1 Global Eosinophilic Esophagitis Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Eosinophilic Esophagitis Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Eosinophilic Esophagitis Drug Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Eosinophilic Esophagitis Drug Market Size YoY Growth 2016-2027
6.1.1 China Eosinophilic Esophagitis Drug Sales YoY Growth 2016-2027
6.1.2 China Eosinophilic Esophagitis Drug Revenue YoY Growth 2016-2027
6.1.3 China Eosinophilic Esophagitis Drug Market Share in Global Market 2016-2027
6.2 China Eosinophilic Esophagitis Drug Market Size by Players (International and Local Players)
6.2.1 China Top Eosinophilic Esophagitis Drug Players by Sales (2016-2021)
6.2.2 China Top Eosinophilic Esophagitis Drug Players by Revenue (2016-2021)
6.3 China Eosinophilic Esophagitis Drug Historic Market Review by Type (2016-2021)
6.3.1 China Eosinophilic Esophagitis Drug Sales Market Share by Type (2016-2021)
6.3.2 China Eosinophilic Esophagitis Drug Revenue Market Share by Type (2016-2021)
6.3.3 China Eosinophilic Esophagitis Drug Price by Type (2016-2021)
6.4 China Eosinophilic Esophagitis Drug Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Eosinophilic Esophagitis Drug Sales Forecast by Type (2022-2027)
6.4.2 China Eosinophilic Esophagitis Drug Revenue Forecast by Type (2022-2027)
6.4.3 China Eosinophilic Esophagitis Drug Price Forecast by Type (2022-2027)
6.5 China Eosinophilic Esophagitis Drug Historic Market Review by Application (2016-2021)
6.5.1 China Eosinophilic Esophagitis Drug Sales Market Share by Application (2016-2021)
6.5.2 China Eosinophilic Esophagitis Drug Revenue Market Share by Application (2016-2021)
6.5.3 China Eosinophilic Esophagitis Drug Price by Application (2016-2021)
6.6 China Eosinophilic Esophagitis Drug Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Eosinophilic Esophagitis Drug Sales Forecast by Application (2022-2027)
6.6.2 China Eosinophilic Esophagitis Drug Revenue Forecast by Application (2022-2027)
6.6.3 China Eosinophilic Esophagitis Drug Price Forecast by Application (2022-2027)
7 North America
7.1 North America Eosinophilic Esophagitis Drug Market Size YoY Growth 2016-2027
7.2 North America Eosinophilic Esophagitis Drug Market Facts & Figures by Country
7.2.1 North America Eosinophilic Esophagitis Drug Sales by Country (2016-2021)
7.2.2 North America Eosinophilic Esophagitis Drug Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Eosinophilic Esophagitis Drug Market Size YoY Growth 2016-2027
8.2 Asia Pacific Eosinophilic Esophagitis Drug Market Facts & Figures by Region
8.2.1 Asia Pacific Eosinophilic Esophagitis Drug Sales by Region (2016-2021)
8.2.2 Asia Pacific Eosinophilic Esophagitis Drug Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Eosinophilic Esophagitis Drug Market Size YoY Growth 2016-2027
9.2 Europe Eosinophilic Esophagitis Drug Market Facts & Figures by Country
9.2.1 Europe Eosinophilic Esophagitis Drug Sales by Country (2016-2021)
9.2.2 Europe Eosinophilic Esophagitis Drug Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Eosinophilic Esophagitis Drug Market Size YoY Growth 2016-2027
10.2 Latin America Eosinophilic Esophagitis Drug Market Facts & Figures by Country
10.2.1 Latin America Eosinophilic Esophagitis Drug Sales by Country (2016-2021)
10.2.2 Latin America Eosinophilic Esophagitis Drug Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Eosinophilic Esophagitis Drug Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Eosinophilic Esophagitis Drug Market Facts & Figures by Country
11.2.1 Middle East and Africa Eosinophilic Esophagitis Drug Sales by Country (2016-2021)
11.2.2 Middle East and Africa Eosinophilic Esophagitis Drug Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 AstraZeneca
12.1.1 AstraZeneca Corporation Information
12.1.2 AstraZeneca Description and Business Overview
12.1.3 AstraZeneca Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 AstraZeneca Eosinophilic Esophagitis Drug Products Offered
12.1.5 AstraZeneca Recent Development
12.2 GSK
12.2.1 GSK Corporation Information
12.2.2 GSK Description and Business Overview
12.2.3 GSK Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 GSK Eosinophilic Esophagitis Drug Products Offered
12.2.5 GSK Recent Development
12.3 Bayer
12.3.1 Bayer Corporation Information
12.3.2 Bayer Description and Business Overview
12.3.3 Bayer Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Bayer Eosinophilic Esophagitis Drug Products Offered
12.3.5 Bayer Recent Development
12.4 Adare Pharmaceuticals
12.4.1 Adare Pharmaceuticals Corporation Information
12.4.2 Adare Pharmaceuticals Description and Business Overview
12.4.3 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Products Offered
12.4.5 Adare Pharmaceuticals Recent Development
12.5 DBV Technologies
12.5.1 DBV Technologies Corporation Information
12.5.2 DBV Technologies Description and Business Overview
12.5.3 DBV Technologies Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 DBV Technologies Eosinophilic Esophagitis Drug Products Offered
12.5.5 DBV Technologies Recent Development
12.6 Dr. Falk Pharma
12.6.1 Dr. Falk Pharma Corporation Information
12.6.2 Dr. Falk Pharma Description and Business Overview
12.6.3 Dr. Falk Pharma Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Dr. Falk Pharma Eosinophilic Esophagitis Drug Products Offered
12.6.5 Dr. Falk Pharma Recent Development
12.7 Quorum Innovations
12.7.1 Quorum Innovations Corporation Information
12.7.2 Quorum Innovations Description and Business Overview
12.7.3 Quorum Innovations Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Quorum Innovations Eosinophilic Esophagitis Drug Products Offered
12.7.5 Quorum Innovations Recent Development
12.8 Takeda
12.8.1 Takeda Corporation Information
12.8.2 Takeda Description and Business Overview
12.8.3 Takeda Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Takeda Eosinophilic Esophagitis Drug Products Offered
12.8.5 Takeda Recent Development
12.9 Calypso
12.9.1 Calypso Corporation Information
12.9.2 Calypso Description and Business Overview
12.9.3 Calypso Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Calypso Eosinophilic Esophagitis Drug Products Offered
12.9.5 Calypso Recent Development
12.10 Celgene
12.10.1 Celgene Corporation Information
12.10.2 Celgene Description and Business Overview
12.10.3 Celgene Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Celgene Eosinophilic Esophagitis Drug Products Offered
12.10.5 Celgene Recent Development
12.11 AstraZeneca
12.11.1 AstraZeneca Corporation Information
12.11.2 AstraZeneca Description and Business Overview
12.11.3 AstraZeneca Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2016-2021)
12.11.4 AstraZeneca Eosinophilic Esophagitis Drug Products Offered
12.11.5 AstraZeneca Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Eosinophilic Esophagitis Drug Industry Trends
13.2 Eosinophilic Esophagitis Drug Market Drivers
13.3 Eosinophilic Esophagitis Drug Market Challenges
13.4 Eosinophilic Esophagitis Drug Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Eosinophilic Esophagitis Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Global Eosinophilic Esophagitis Drug Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Budesonide
Table 3. Major Manufacturers of Fluticasone
Table 4. Major Manufacturers of Others
Table 5. Global Eosinophilic Esophagitis Drug Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 6. Global Eosinophilic Esophagitis Drug Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 7. Global Eosinophilic Esophagitis Drug Sales by Regions (2016-2021) & (K Units)
Table 8. Global Eosinophilic Esophagitis Drug Sales Market Share by Regions (2016-2021)
Table 9. Global Eosinophilic Esophagitis Drug Revenue by Regions (2016-2021) & (US$ Million)
Table 10. Global Eosinophilic Esophagitis Drug Sales Forecast by Region (2022-2027) & (K Units)
Table 11. Global Eosinophilic Esophagitis Drug Sales Market Share Forecast by Region (2022-2027)
Table 12. Global Eosinophilic Esophagitis Drug Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 13. Global Eosinophilic Esophagitis Drug Revenue Market Share Forecast by Region (2022-2027)
Table 14. Global Eosinophilic Esophagitis Drug Sales by Manufacturers (2016-2021) (K Units)
Table 15. Global Eosinophilic Esophagitis Drug Sales Share by Manufacturers (2016-2021)
Table 16. Ranking of Global Top Eosinophilic Esophagitis Drug Manufacturers by Revenue (US$ Million) in 2020
Table 17. Eosinophilic Esophagitis Drug Revenue by Manufacturers (2016-2021) (US$ Million)
Table 18. Eosinophilic Esophagitis Drug Revenue Share by Manufacturers (2016-2021)
Table 19. Global Eosinophilic Esophagitis Drug Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 20. Global Eosinophilic Esophagitis Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Eosinophilic Esophagitis Drug as of 2020)
Table 21. Key Manufacturers Eosinophilic Esophagitis Drug Price (2016-2021) (USD/Unit)
Table 22. Eosinophilic Esophagitis Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Eosinophilic Esophagitis Drug Product Type
Table 24. Date of International Manufacturers Enter into Eosinophilic Esophagitis Drug Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Eosinophilic Esophagitis Drug Sales by Type (2016-2021) (K Units)
Table 27. Global Eosinophilic Esophagitis Drug Sales Share by Type (2016-2021)
Table 28. Global Eosinophilic Esophagitis Drug Revenue by Type (2016-2021) (US$ Million)
Table 29. Global Eosinophilic Esophagitis Drug Revenue Share by Type (2016-2021)
Table 30. Eosinophilic Esophagitis Drug Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Table 31. Global Eosinophilic Esophagitis Drug Sales Forecast by Type (2022-2027) & (K Units)
Table 32. Global Eosinophilic Esophagitis Drug Sales Market Share Forecast by Type (2022-2027)
Table 33. Global Eosinophilic Esophagitis Drug Revenue Forecast V (2022-2027) & (US$ Million)
Table 34. Global Eosinophilic Esophagitis Drug Revenue Market Share Forecast by Type (2022-2027)
Table 35. Global Eosinophilic Esophagitis Drug Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit)
Table 36. Global Eosinophilic Esophagitis Drug Sales by Application (2016-2021) (K Units)
Table 37. Global Eosinophilic Esophagitis Drug Sales Share by Application (2016-2021)
Table 38. Global Eosinophilic Esophagitis Drug Revenue by Application (2016-2021) (US$ Million)
Table 39. Global Eosinophilic Esophagitis Drug Revenue Share by Application (2016-2021)
Table 40. Eosinophilic Esophagitis Drug Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Table 41. Global Eosinophilic Esophagitis Drug Sales Forecast by Application (2022-2027) & (K Units)
Table 42. Global Eosinophilic Esophagitis Drug Sales Market Share Forecast by Application (2022-2027)
Table 43. Global Eosinophilic Esophagitis Drug Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 44. Global Eosinophilic Esophagitis Drug Revenue Market Share Forecast by Application (2022-2027)
Table 45. Global Eosinophilic Esophagitis Drug Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit)
Table 46. China Eosinophilic Esophagitis Drug Sales (K Units) of Key Companies (2016-2021)
Table 47. China Eosinophilic Esophagitis Drug Sales Share by Company (2016-2021)
Table 48. China Eosinophilic Esophagitis Drug Revenue (US$ Million) by Company (2016-2021)
Table 49. China Eosinophilic Esophagitis Drug Revenue Share by Company (2016-2021)
Table 50. China Eosinophilic Esophagitis Drug Sales (K Units) by Type (2016-2021)
Table 51. China Eosinophilic Esophagitis Drug Sales Share by Type (2016-2021)
Table 52. China Eosinophilic Esophagitis Drug Revenue (US$ Million) Market Share by Type (2016-2021)
Table 53. China Eosinophilic Esophagitis Drug Price (USD/Unit) by Type (2016-2021)
Table 54. China Eosinophilic Esophagitis Drug Sales (K Units) by Type (2022-2027)
Table 55. China Eosinophilic Esophagitis Drug Sales Share by Type (2022-2027)
Table 56. China Eosinophilic Esophagitis Drug Revenue (US$ Million) Market Share by Type (2022-2027)
Table 57. China Eosinophilic Esophagitis Drug Revenue Share by Type (2022-2027)
Table 58. China Eosinophilic Esophagitis Drug Price (USD/Unit) by Type (2022-2027)
Table 59. China Eosinophilic Esophagitis Drug Sales (K Units) by Application (2016-2021)
Table 60. China Eosinophilic Esophagitis Drug Sales Share by Application (2016-2021)
Table 61. China Eosinophilic Esophagitis Drug Revenue (US$ Million) Market Share by Application (2016-2021)
Table 62. China Eosinophilic Esophagitis Drug Price (USD/Unit) by Application (2016-2021)
Table 63. China Eosinophilic Esophagitis Drug Sales (K Units) by Application (2022-2027)
Table 64. China Eosinophilic Esophagitis Drug Sales Share by Application (2022-2027)
Table 65. China Eosinophilic Esophagitis Drug Revenue (US$ Million) Market Share by Application (2022-2027)
Table 66. China Eosinophilic Esophagitis Drug Revenue Share by Application (2022-2027)
Table 67. China Eosinophilic Esophagitis Drug Price (USD/Unit) by Application (2022-2027)
Table 68. North America Eosinophilic Esophagitis Drug Sales by Country (2016-2021) & (K Units)
Table 69. North America Eosinophilic Esophagitis Drug Sales Market Share by Country (2016-2021)
Table 70. North America Eosinophilic Esophagitis Drug Revenue by Country (2016-2021) & (US$ Million)
Table 71. North America Eosinophilic Esophagitis Drug Revenue Market Share by Country (2016-2021)
Table 72. Asia Pacific Eosinophilic Esophagitis Drug Sales by Region (2016-2021) & (K Units)
Table 73. Asia Pacific Eosinophilic Esophagitis Drug Sales Market Share by Region (2016-2021)
Table 74. Asia Pacific Eosinophilic Esophagitis Drug Revenue by Region (2016-2021) & (US$ Million)
Table 75. Asia Pacific Eosinophilic Esophagitis Drug Revenue Market Share by Region (2016-2021)
Table 76. Europe Eosinophilic Esophagitis Drug Sales by Country (2016-2021) & (K Units)
Table 77. Europe Eosinophilic Esophagitis Drug Sales Market Share by Country (2016-2021)
Table 78. Europe Eosinophilic Esophagitis Drug Revenue by Country (2016-2021) & (US$ Million)
Table 79. Europe Eosinophilic Esophagitis Drug Revenue Market Share by Country (2016-2021)
Table 80. Latin America Eosinophilic Esophagitis Drug Sales by Country (2016-2021) & (K Units)
Table 81. Latin America Eosinophilic Esophagitis Drug Sales Market Share by Country (2016-2021)
Table 82. Latin Americaa Eosinophilic Esophagitis Drug Revenue by Country (2016-2021) & (US$ Million)
Table 83. Latin America Eosinophilic Esophagitis Drug Revenue Market Share by Country (2016-2021)
Table 84. Middle East and Africa Eosinophilic Esophagitis Drug Sales by Country (2016-2021) & (K Units)
Table 85. Middle East and Africa Eosinophilic Esophagitis Drug Sales Market Share by Country (2016-2021)
Table 86. Middle East and Africa Eosinophilic Esophagitis Drug Revenue by Country (2016-2021) & (US$ Million)
Table 87. Middle East and Africa Eosinophilic Esophagitis Drug Revenue Market Share by Country (2016-2021)
Table 88. AstraZeneca Corporation Information
Table 89. AstraZeneca Description and Business Overview
Table 90. AstraZeneca Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. AstraZeneca Eosinophilic Esophagitis Drug Product
Table 92. AstraZeneca Recent Development
Table 93. GSK Corporation Information
Table 94. GSK Description and Business Overview
Table 95. GSK Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. GSK Product
Table 97. GSK Recent Development
Table 98. Bayer Corporation Information
Table 99. Bayer Description and Business Overview
Table 100. Bayer Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 101. Bayer Product
Table 102. Bayer Recent Development
Table 103. Adare Pharmaceuticals Corporation Information
Table 104. Adare Pharmaceuticals Description and Business Overview
Table 105. Adare Pharmaceuticals Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 106. Adare Pharmaceuticals Product
Table 107. Adare Pharmaceuticals Recent Development
Table 108. DBV Technologies Corporation Information
Table 109. DBV Technologies Description and Business Overview
Table 110. DBV Technologies Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 111. DBV Technologies Product
Table 112. DBV Technologies Recent Development
Table 113. Dr. Falk Pharma Corporation Information
Table 114. Dr. Falk Pharma Description and Business Overview
Table 115. Dr. Falk Pharma Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 116. Dr. Falk Pharma Product
Table 117. Dr. Falk Pharma Recent Development
Table 118. Quorum Innovations Corporation Information
Table 119. Quorum Innovations Description and Business Overview
Table 120. Quorum Innovations Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 121. Quorum Innovations Product
Table 122. Quorum Innovations Recent Development
Table 123. Takeda Corporation Information
Table 124. Takeda Description and Business Overview
Table 125. Takeda Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 126. Takeda Product
Table 127. Takeda Recent Development
Table 128. Calypso Corporation Information
Table 129. Calypso Description and Business Overview
Table 130. Calypso Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 131. Calypso Product
Table 132. Calypso Recent Development
Table 133. Celgene Corporation Information
Table 134. Celgene Description and Business Overview
Table 135. Celgene Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 136. Celgene Product
Table 137. Celgene Recent Development
Table 138. Regeneron Corporation Information
Table 139. Regeneron Description and Business Overview
Table 140. Regeneron Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 141. Regeneron Product
Table 142. Regeneron Recent Development
Table 143. Eosinophilic Esophagitis Drug Market Trends
Table 144. Eosinophilic Esophagitis Drug Market Drivers
Table 145. Eosinophilic Esophagitis Drug Market Challenges
Table 146. Eosinophilic Esophagitis Drug Market Restraints
Table 147. Eosinophilic Esophagitis Drug Customers List
Table 148. Eosinophilic Esophagitis Drug Distributors List
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Eosinophilic Esophagitis Drug Product Picture
Figure 2. Global Eosinophilic Esophagitis Drug Sales Market Share by Type in 2020 & 2027
Figure 3. Budesonide Product Picture
Figure 4. Fluticasone Product Picture
Figure 5. Others Product Picture
Figure 6. Global Eosinophilic Esophagitis Drug Sales Market Share by Application in 2020 & 2027
Figure 7. Hospitals
Figure 8. Clinics
Figure 9. Drugstore
Figure 10. Eosinophilic Esophagitis Drug Report Years Considered
Figure 11. Global Eosinophilic Esophagitis Drug Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Eosinophilic Esophagitis Drug Market Size 2016-2027 (US$ Million)
Figure 13. Global Eosinophilic Esophagitis Drug Sales 2016-2027 (K Units)
Figure 14. Global Eosinophilic Esophagitis Drug Market Size Market Share by Region: 2021 Versus 2027
Figure 15. Global Eosinophilic Esophagitis Drug Sales Market Share by Region (2016-2021)
Figure 16. Global Eosinophilic Esophagitis Drug Sales Market Share by Region in 2020
Figure 17. Global Eosinophilic Esophagitis Drug Revenue Market Share by Region (2016-2021)
Figure 18. Global Eosinophilic Esophagitis Drug Revenue Market Share by Region in 2020
Figure 19. Global Eosinophilic Esophagitis Drug Sales Share by Manufacturer in 2020
Figure 20. The Top 10 and 5 Players Market Share by Eosinophilic Esophagitis Drug Revenue in 2020
Figure 21. Eosinophilic Esophagitis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 22. Global Eosinophilic Esophagitis Drug Sales Market Share by Type (2016-2021)
Figure 23. Global Eosinophilic Esophagitis Drug Sales Market Share by Type in 2020
Figure 24. Global Eosinophilic Esophagitis Drug Revenue Market Share by Type (2016-2021)
Figure 25. Global Eosinophilic Esophagitis Drug Revenue Market Share by Type in 2020
Figure 26. Global Eosinophilic Esophagitis Drug Sales Market Share by Application (2016-2021)
Figure 27. Global Eosinophilic Esophagitis Drug Sales Market Share by Application in 2020
Figure 28. Global Eosinophilic Esophagitis Drug Revenue Market Share by Application (2016-2021)
Figure 29. Global Eosinophilic Esophagitis Drug Revenue Market Share by Application in 2020
Figure 30. China Eosinophilic Esophagitis Drug Sales Growth Rate 2016-2027 (K Units)
Figure 31. China Eosinophilic Esophagitis Drug Revenue Growth Rate 2016-2027 (US$ Million)
Figure 32. China Eosinophilic Esophagitis Drug Market Share in Global Market 2016-2027
Figure 33. China 5 and 10 Largest Eosinophilic Esophagitis Drug Players Market Share by Revenue in Eosinophilic Esophagitis Drug in 2020
Figure 34. China Eosinophilic Esophagitis Drug Revenue Share by Type (2016-2021)
Figure 35. China Eosinophilic Esophagitis Drug Revenue Growth Rate by Type in 2016 & 2020
Figure 36. China Eosinophilic Esophagitis Drug Revenue Share by Application (2016-2021)
Figure 37. China Eosinophilic Esophagitis Drug Revenue Growth Rate by Application in 2016 & 2020
Figure 38. North America Eosinophilic Esophagitis Drug Sales Growth Rate 2016-2021 (K Units)
Figure 39. North America Eosinophilic Esophagitis Drug Revenue Growth Rate 2016-2021 (US$ Million)
Figure 40. North America Eosinophilic Esophagitis Drug Sales Market Share by Country in 2020
Figure 41. North America Eosinophilic Esophagitis Drug Revenue Market Share by Country in 2020
Figure 42. U.S. Eosinophilic Esophagitis Drug Sales Growth Rate (2016-2021) (K Units)
Figure 43. U.S. Eosinophilic Esophagitis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Canada Eosinophilic Esophagitis Drug Sales Growth Rate (2016-2021) (K Units)
Figure 45. Canada Eosinophilic Esophagitis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Europe Eosinophilic Esophagitis Drug Sales Growth Rate 2016-2021 (K Units)
Figure 47. Europe Eosinophilic Esophagitis Drug Revenue Growth Rate 2016-2021 (US$ Million)
Figure 48. Europe Eosinophilic Esophagitis Drug Sales Market Share by Country in 2020
Figure 49. Europe Eosinophilic Esophagitis Drug Revenue Market Share by Country in 2020
Figure 50. Germany Eosinophilic Esophagitis Drug Sales Growth Rate (2016-2021) (K Units)
Figure 51. Germany Eosinophilic Esophagitis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. France Eosinophilic Esophagitis Drug Sales Growth Rate (2016-2021) (K Units)
Figure 53. France Eosinophilic Esophagitis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. U.K. Eosinophilic Esophagitis Drug Sales Growth Rate (2016-2021) (K Units)
Figure 55. U.K. Eosinophilic Esophagitis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. Italy Eosinophilic Esophagitis Drug Sales Growth Rate (2016-2021) (K Units)
Figure 57. Italy Eosinophilic Esophagitis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Russia Eosinophilic Esophagitis Drug Sales Growth Rate (2016-2021) (K Units)
Figure 59. Russia Eosinophilic Esophagitis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. Asia Pacific Eosinophilic Esophagitis Drug Sales Growth Rate 2016-2021 (K Units)
Figure 61. Asia Pacific Eosinophilic Esophagitis Drug Revenue Growth Rate 2016-2021 (US$ Million)
Figure 62. Asia Pacific Eosinophilic Esophagitis Drug Sales Market Share by Region in 2020
Figure 63. Asia Pacific Eosinophilic Esophagitis Drug Revenue Market Share by Region in 2020
Figure 64. China Eosinophilic Esophagitis Drug Sales Growth Rate (2016-2021) (K Units)
Figure 65. China Eosinophilic Esophagitis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 66. Japan Eosinophilic Esophagitis Drug Sales Growth Rate (2016-2021) (K Units)
Figure 67. Japan Eosinophilic Esophagitis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. South Korea Eosinophilic Esophagitis Drug Sales Growth Rate (2016-2021) (K Units)
Figure 69. South Korea Eosinophilic Esophagitis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. India Eosinophilic Esophagitis Drug Sales Growth Rate (2016-2021) (K Units)
Figure 71. India Eosinophilic Esophagitis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. Australia Eosinophilic Esophagitis Drug Sales Growth Rate (2016-2021) (K Units)
Figure 73. Australia Eosinophilic Esophagitis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. Taiwan Eosinophilic Esophagitis Drug Sales Growth Rate (2016-2021) (K Units)
Figure 75. Taiwan Eosinophilic Esophagitis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Indonesia Eosinophilic Esophagitis Drug Sales Growth Rate (2016-2021) (K Units)
Figure 77. Indonesia Eosinophilic Esophagitis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Thailand Eosinophilic Esophagitis Drug Sales Growth Rate (2016-2021) (K Units)
Figure 79. Thailand Eosinophilic Esophagitis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Malaysia Eosinophilic Esophagitis Drug Sales Growth Rate (2016-2021) (K Units)
Figure 81. Malaysia Eosinophilic Esophagitis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Philippines Eosinophilic Esophagitis Drug Sales Growth Rate (2016-2021) (K Units)
Figure 83. Philippines Eosinophilic Esophagitis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 84. Vietnam Eosinophilic Esophagitis Drug Sales Growth Rate (2016-2021) (K Units)
Figure 85. Vietnam Eosinophilic Esophagitis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 86. Latin America Eosinophilic Esophagitis Drug Sales Growth Rate 2016-2021 (K Units)
Figure 87. Latin America Eosinophilic Esophagitis Drug Revenue Growth Rate 2016-2021 (US$ Million)
Figure 88. Latin America Eosinophilic Esophagitis Drug Sales Market Share by Country in 2020
Figure 89. Latin America Eosinophilic Esophagitis Drug Revenue Market Share by Country in 2020
Figure 90. Mexico Eosinophilic Esophagitis Drug Sales Growth Rate (2016-2021) (K Units)
Figure 91. Mexico Eosinophilic Esophagitis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 92. Brazil Eosinophilic Esophagitis Drug Sales Growth Rate (2016-2021) (K Units)
Figure 93. Brazil Eosinophilic Esophagitis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 94. Argentina Eosinophilic Esophagitis Drug Sales Growth Rate (2016-2021) (K Units)
Figure 95. Argentina Eosinophilic Esophagitis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 96. Middle East and Africa Eosinophilic Esophagitis Drug Sales Growth Rate 2016-2021 (K Units)
Figure 97. Middle East and Africa Eosinophilic Esophagitis Drug Revenue Growth Rate 2016-2021 (US$ Million)
Figure 98. Middle East and Africa Eosinophilic Esophagitis Drug Sales Market Share by Country in 2020
Figure 99. Middle East and Africa Eosinophilic Esophagitis Drug Revenue Market Share by Country in 2020
Figure 100. Turkey Eosinophilic Esophagitis Drug Sales Growth Rate (2016-2021) (K Units)
Figure 101. Turkey Eosinophilic Esophagitis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 102. Saudi Arabia Eosinophilic Esophagitis Drug Sales Growth Rate (2016-2021) (K Units)
Figure 103. Saudi Arabia Eosinophilic Esophagitis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 104. U.A.E Eosinophilic Esophagitis Drug Sales Growth Rate (2016-2021) (K Units)
Figure 105. U.A.E Eosinophilic Esophagitis Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 106. Eosinophilic Esophagitis Drug Value Chain
Figure 107. Channels of Distribution
Figure 108. Distributors Profiles
Figure 109. Bottom-up and Top-down Approaches for This Report
Figure 110. Data Triangulation
Figure 111. Key Executives Interviewed
世界のJAK阻害薬市場インサイト・予測（～2027年） Janus kinase inhibitors, also known as JAK inhibitors or jakinibs, are a type of medication that functions by inhibiting the activity of one or more of the Janus kinase family of enzymes (JAK1, JAK2, JAK3, TYK2), thereby interfering with the JAK-STAT signaling pathway. Market Analysis and Insights: …- 世界のJAK阻害薬市場インサイト・予測（～2027年） Janus kinase inhibitors, also known as JAK inhibitors or jakinibs, are a type of medication that functions by inhibiting the activity of one or more of the Janus kinase family of enzymes (JAK1, JAK2, JAK3, TYK2), thereby interfering with the JAK-STAT signaling pathway. Market Analysis and Insights: …
- 世界のJAK阻害剤ベース抗がん剤市場インサイト・予測（～2027年） JAK inhibitor I is a JAK1/2/3 inhibitor that decreased cell proliferation in breast cancer cells, increased apoptosis in esophageal squamous cell carcinoma cancer stem cells, inhibited STAT3 phosphorylation in HCC cells, and, in combination with cisplatin, decreased PD-L1 expression in prostate canc…
- 世界のJAK阻害剤ベース抗がん剤市場インサイト・予測（～2027年） JAK inhibitor I is a JAK1/2/3 inhibitor that decreased cell proliferation in breast cancer cells, increased apoptosis in esophageal squamous cell carcinoma cancer stem cells, inhibited STAT3 phosphorylation in HCC cells, and, in combination with cisplatin, decreased PD-L1 expression in prostate canc…
- スニチニブ薬の世界市場 2020年 Market Overview The global Sunitinib Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Sunitinib Drug market report p…